Screener
Cogent Biosciences, Inc. COGT Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342393
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net loss per share, basic and diluted, common stock | $(0.52) | $(0.53) | $(1.05) | $(1.05) |
| Weighted average common stock outstanding, basic and diluted | 171,005,468 | 114,466,080 | 166,624,462 | 114,463,810 |
| Comprehensive loss: | ||||
| Net loss | $(96,405) | $(73,529) | $(193,757) | $(145,515) |
| Other comprehensive income (loss): | ||||
| Net unrealized gains (losses) on marketable securities | (355) | (151) | (1,125) | (434) |
| Total other comprehensive income (loss) | (355) | (151) | (1,125) | (434) |
| Comprehensive loss | $(96,760) | $(73,680) | $(194,882) | $(145,949) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Cogent Biosciences, Inc. (COGT) reported comprehensive income (loss), net of tax, attributable to parent of -$96.76M in Q2 2026.
- How has Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 31.3% year-over-year, from -$73.68M to -$96.76M.
- What is the long-term trend for Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 46.1% compound annual growth rate (CAGR), from -$72.24M to -$329.03M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric combines net income with other comprehensive income to provide a holistic view of the total change in shareholder equity during the period. It accounts for all financial activities, including operational results and unrealized market fluctuations. This figure is essential for assessing the total economic impact of the company's activities on its capital base.
Ask your AI about Cogent Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude